1-4 of 4
Neil Hawkins
Close
Sort by
Journal Articles

Estimating the Effect of Individual Agents in the Treatment of Relapsed, Refractory Multiple Myeloma (RRMM)

Neil Hawkins, Karthik Ramasamy, Sujith Dhanasiri
Journal: Blood
Blood (2018) 132 (Supplement 1): 2013.
https://doi.org/10.1182/blood-2018-99-111804
Published: 2018
Journal Articles

Comparative Efficacy Among 3 rd Line Post-Imatinib Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients after Failure of Dasatinib or Nilotinib Tyrosine Kinase Inhibitors

Jeffrey H. Lipton, MD PhD, Dhvani Shah, MS, Vanita Tongbram, MBBS, MPH, Manpreet K Sidhu, BA, PhD MBA, Hui Huang, PhD MBA, Lisa J McGarry, MPH, Stephanie Lustgarten, PhD, Neil Hawkins, PhD
Journal: Blood
Blood (2014) 124 (21): 4551.
https://doi.org/10.1182/blood.V124.21.4551.4551
Published: 2014
Journal Articles

Comparative Efficacy Among Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients After Failure Of 2 nd Generation Tyrosine Kinase Inhibitors (2G TKIs)

Jeff H. Lipton, PhD, MD, Peter Bryden, MSc, BSc, Manpreet K Sidhu, BA, PhD, MBA, Hui Huang, PhD, MBA, Lisa J McGarry, BA, MPH, ABD DSc, Stephanie Lustgarten, PhD, Beth Woods, MSc, BA, Neil Hawkins, PhD
Journal: Blood
Blood (2013) 122 (21): 4010.
https://doi.org/10.1182/blood.V122.21.4010.4010
Published: 2013
Journal Articles

Comparative Efficacy of First Line Treatment of Chronic Myeloid Leukaemia (CML): A Systematic Review and Meta-Analysis.

Stuart Mealing, MSc, Leticia Barcena, Ldo.Vet, Neil Hawkins, PhD, James Clark, MBiochem, Catherine Davis, PharmD
Journal: Blood
Blood (2010) 116 (21): 3436.
https://doi.org/10.1182/blood.V116.21.3436.3436
Published: 2010